Bluejay Diagnostics Inc. (BJDX) Financial Statements (2024 and earlier)

Company Profile

Business Address 360 MASSACHUSETTS AVENUE, SUITE 203
ACTON, MA 01720
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,20910,11519,048
Cash and cash equivalents2,20910,11519,048
Receivables   
Prepaid expense1881,673160
Deferred costs 265  
Other undisclosed current assets559 1,452
Total current assets:3,22111,78820,660
Noncurrent Assets
Operating lease, right-of-use asset333466 
Property, plant and equipment1,2861,232337
Other noncurrent assets293521
Total noncurrent assets:1,6481,733358
TOTAL ASSETS:4,86913,52121,019
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,608836339
Employee-related liabilities158
Accounts payable491636296
Accrued liabilities1,117836339
Other undisclosed accounts payable and accrued liabilities  (636)(454)
Debt5 5
Due to related parties22
Other undisclosed current liabilities158803 
Total current liabilities:1,7711,640346
Noncurrent Liabilities
Liabilities, other than long-term debt202340 
Other liabilities1216 
Operating lease, liability190324 
Total noncurrent liabilities:202340 
Other undisclosed liabilities   291
Total liabilities:1,9741,980637
Equity
Equity, attributable to parent2,89511,54120,382
Common stock022
Additional paid in capital29,84628,53628,074
Accumulated deficit(26,951)(16,997)(7,695)
Total equity:2,89511,54120,382
TOTAL LIABILITIES AND EQUITY:4,86913,52121,019

Income Statement (P&L) ($ in thousands)

6/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
Revenues 24920
Other income 25820
Cost of revenue
(Cost of Goods and Services Sold)
  (200) 
Gross profit: 4920
Operating expenses(10,311)(9,367)(3,230)
Other undisclosed operating loss  (20)
Operating loss:(10,311)(9,318)(3,230)
Nonoperating income (expense)35721(258)
Other nonoperating income (expense)192  
Interest and debt expense  6(9)
Loss from continuing operations:(9,954)(9,291)(3,497)
Loss before gain (loss) on sale of properties:(3,497)
Other undisclosed net income   9
Net loss:(9,954)(9,291)(3,488)
Other undisclosed net loss attributable to parent  (6) 
Net loss available to common stockholders, diluted:(9,954)(9,297)(3,488)

Comprehensive Income ($ in thousands)

6/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
Net loss:(9,954)(9,291)(3,488)
Comprehensive loss, net of tax, attributable to parent:(9,954)(9,291)(3,488)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: